Ratings Zhejiang NHU Company Ltd.

Equities

002001

CNE000001J84

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-04-21 pm EDT			5-day change	1st Jan Change
17.54 ^CNY	-0.62%		+1.50%	+3.42%

2023	Zhejiang NHU Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
2023	Zhejiang NHU Company Ltd. Announces Executive Appointments	CI

Summary

The company has a poor ESG score according to Refinitiv, which ranks companies by sector.

Strengths

The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
The group's activity appears highly profitable thanks to its outperforming net margins.

Weaknesses

The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company's enterprise value to sales, at 3.89 times its current sales, is high.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Food Processing

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
ZHEJIANG NHU COMPANY LTD.	+3.42%	7.44B		D+
BELLRING BRANDS, INC.	-2.62%	7.21B		C-
CSPC INNOVATION PHARMACEUTICAL CO., LTD.	-2.02%	5.8B		-
BYHEALTH CO., LTD	-8.81%	3.65B		D
THE SIMPLY GOOD FOODS COMPANY	-16.89%	3.29B		B-
XIAMEN KINGDOMWAY GROUP COMPANY	-15.49%	1.16B	-	-
SIRIO PHARMA CO., LTD.	+8.17%	940M		-
HERBALIFE LTD.	-40.43%	907M		B+
USANA HEALTH SCIENCES, INC.	-17.48%	851M		C+
JAMIESON WELLNESS INC.	-17.46%	791M		C+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes